caresyntax Revenue and Competitors

Boston, MA USA

Location

$207.5M

Total Funding

Estimated Revenue & Valuation

  • caresyntax's estimated annual revenue is currently $28M per year.(i)
  • caresyntax's estimated revenue per employee is $150,500
  • caresyntax's total funding is $207.5M.

Employee Data

  • caresyntax has 186 Employees.(i)
  • caresyntax grew their employee count by -2% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.3M8813%N/AN/A
#2
$1.2M14-33%N/AN/A
#3
$5.3M50-26%$29.3MN/A
#4
$24.7M164-5%$45.2MN/A
#5
$4.8M435%N/AN/A
#6
$77M0N/A$866MN/A
#7
$0.3M4-33%N/AN/A
#8
$3.9M3525%N/AN/A
#9
$234.6M11978%N/AN/A
#10
$18.6M133-16%$23.3MN/A
Add Company

caresyntax® solutions and services enable surgical care providers to reduce risk using actionable clinical data, made available through a combination of IoT and data analytics technologies. Trusted in over 6,000 ORs worldwide, caresyntax helps surgeons and healthcare executives to manage surgical risk and quality, and improve outcomes in over 10 million procedures per year. Why join us? Headquartered in Berlin and Boston, with over 90 employees of 20 different nationalities, our company is a highly talented and international workforce, attracting great minds alike. We embrace knowledge exchange across teams and departments, and place a strong emphasis on developing our own talent. We work objectively and analytically, and employ modern, agile methods. Learn more: https://caresyntax.com/about/ We are currently looking for talented Full Stack Java Developers (fluent English is a must, German is optional) as well as driven Product, Marketing and Sales professionals in our Berlin office. Get in touch with Jacky ?palek under careers@caresyntax.com or via LinkedIn messenger to discuss your potential career with us.

keywords:saas

$207.5M

Total Funding

186

Number of Employees

$28M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

caresyntax's People

NameTitleEmail/Phone
1
Director, PMO (US/ANZ)Reveal Email/Phone
2
Executive Director, Global Market DevelopmentReveal Email/Phone
3
Executive Assistant, US Office CoordinatorReveal Email/Phone
4
Global Director Product ManagementReveal Email/Phone
5
VP, Global Quality and Regulatory AffairsReveal Email/Phone
6
Global Marketing DirectorReveal Email/Phone
7
Business Development ConsultantReveal Email/Phone
8
Director, Customer SuccessReveal Email/Phone
9
VP Software EngineeringReveal Email/Phone
10
EVP, Chief Technology OfficerReveal Email/Phone

caresyntax News

2022-04-13 - Global Artificial Intelligence (AI) in Operating Room Market ...

... in Operating Room Market Witness Extraordinary Extension In Upcoming Years | Activ Surgical Inc., Brainomix Limited, Caresyntax Corp...

2021-09-17 - Caresyntax Raises Additional $30M; Brings Series C To $130M

Caresyntax, a Boston WA-based digital surgery platform, raised an additional $30M which brought total Series C to $130M. This round was led by PFM Health Sciences, with participation from funds and accounts managed by BlackRock, as well as ProAssurance, Harmonix, and existing investors such as ...

2021-09-16 - Caresyntax : extends Series C funding to $130 Million to further accelerate growth

DGAP-Media / 16.09.2021 / 11:55 Caresyntax extends Series C funding to $130 Million to further accelerate growth New investors include funds managed by BlackRock, ProAssurance, and Harmonix $30 million extension raises Series C funding to a total of $130 million Funding to drive further develo ...

2021-09-16 - Caresyntax Raises Additional $30M for Digital Surgery Platform

– Caresyntax, a digital surgery platform, today announced a $30M extension to its Series C funding round included participation from BlackRock, ProAssurance, and Harmonix. In addition to existing investors such as the Relyens Group and IPF Partners. This extension brings the total Series C fundi ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$66.1M186-1%N/A
#2
$26.6M186-12%$43M
#3
$28.1M187-1%$26.6M
#4
$28.1M18713%$38.7M
#5
$50.5M1874%$42M